These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31469901)

  • 1. Universal Genetic Testing for All Breast Cancer Patients.
    Copur MS
    Oncology (Williston Park); 2019 Aug; 33(8):. PubMed ID: 31469901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary Breast Cancer: BRCA Mutations and Beyond.
    Patel MM; Adrada BE
    Radiol Clin North Am; 2024 Jul; 62(4):627-642. PubMed ID: 38777539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2.
    Fabi A; Cortesi L; Duranti S; Cordisco EL; Di Leone A; Terribile D; Paris I; de Belvis AG; Orlandi A; Marazzi F; Muratore M; Garganese G; Fuso P; Paoletti F; Dell'Aquila R; Minucci A; Scambia G; Franceschini G; Masetti R; Genuardi M
    Crit Rev Oncol Hematol; 2024 Sep; 201():104431. PubMed ID: 38977141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline.
    Bedrosian I; Somerfield MR; Achatz MI; Boughey JC; Curigliano G; Friedman S; Kohlmann WK; Kurian AW; Laronga C; Lynce F; Norquist BS; Plichta JK; Rodriguez P; Shah PD; Tischkowitz M; Wood M; Yadav S; Yao K; Robson ME
    J Clin Oncol; 2024 Feb; 42(5):584-604. PubMed ID: 38175972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic counseling and genetic testing for pathogenic germline mutations among high-risk patients previously diagnosed with breast cancer: a traceback approach.
    Abdel-Razeq H; Tamimi F; Iweir S; Sharaf B; Abdel-Razeq S; Salama O; Edaily S; Bani Hani H; Azzam K; Abaza H
    Sci Rep; 2024 Jun; 14(1):12820. PubMed ID: 38834641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal genetic counseling in breast cancer patients significantly improves overall testing rates and improves completion rates in subpopulations.
    Elson NC; Wernke K; Yoder LM; Fellner AN; Raque KM; Kuritzky AM; Wexelman BA
    Breast Cancer Res Treat; 2024 Aug; 207(1):25-32. PubMed ID: 38822953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons.
    Manahan ER; Kuerer HM; Sebastian M; Hughes KS; Boughey JC; Euhus DM; Boolbol SK; Taylor WA
    Ann Surg Oncol; 2019 Oct; 26(10):3025-3031. PubMed ID: 31342359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer genetic counselling for hereditary breast cancer in the era of precision oncology.
    Pensabene M; Calabrese A; von Arx C; Caputo R; De Laurentiis M
    Cancer Treat Rev; 2024 Apr; 125():102702. PubMed ID: 38452709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicians' experiences with BRCA1/2 testing in community settings.
    Keating NL; Stoeckert KA; Regan MM; DiGianni L; Garber JE
    J Clin Oncol; 2008 Dec; 26(35):5789-96. PubMed ID: 19001322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention, diagnosis and clinical management of hereditary breast cancer beyond BRCA1/2 genes.
    Calabrese A; von Arx C; Tafuti AA; Pensabene M; De Laurentiis M
    Cancer Treat Rev; 2024 Sep; 129():102785. PubMed ID: 38870570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncommon variants detected via hereditary cancer panel and suggestions for genetic counseling.
    Özdemir Z; Çevik E; Öksüzoğlu ÖBÇ; Doğan M; Ateş Ö; Esin E; Bilgetekin İ; Demirci U; Köseoğlu Ç; Topal A; Karadurmuş N; Erdem HB; Bahsi T
    Mutat Res; 2023; 827():111831. PubMed ID: 37453313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary care providers' willingness to recommend BRCA1/2 testing to adolescents.
    O'Neill SC; Peshkin BN; Luta G; Abraham A; Walker LR; Tercyak KP
    Fam Cancer; 2010 Mar; 9(1):43-50. PubMed ID: 19390990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of breast cancer patients with
    Abdel-Razeq H; Abbasi S; Abdeen G; Abdulelah H; Debs J; Al Masri S; Aljadayeh MH; Awidi A
    Hosp Pract (1995); 2023 Oct; 51(4):184-191. PubMed ID: 37927299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges to genetic testing for germline mutations associated with breast cancer among African Americans.
    Kamaraju S; Conroy M; Harris A; Georgen M; Min H; Powell M; Kurzrock R
    Cancer Treat Rev; 2024 Mar; 124():102695. PubMed ID: 38325071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of changing guidelines on genetic testing and surveillance recommendations in a contemporary cohort of breast cancer survivors with family history of pancreatic cancer.
    Wang A; Everett JN; Chun J; Cen C; Simeone DM; Schnabel F
    Sci Rep; 2021 Jun; 11(1):12491. PubMed ID: 34127761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic testing and counseling challenges in personalized breast cancer care: review article with insights from Türkiye.
    Cicin I; Karadurmus N; Bilici A; Bahsi T; Sendur MA; Demirci U; Goksu SS; Er O; Bisgin A; Ozturk Saglam OF; Aver B; Kilickap S
    Future Oncol; 2024 May; 20(15):1031-1045. PubMed ID: 38014519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cost-utility analysis of
    Lertwilaiwittaya P; Tantai N; Maneeon S; Kongbunrak S; Nonpanya N; Hurst ACE; Srinonprasert V; Pithukpakorn M
    Front Public Health; 2023; 11():1257668. PubMed ID: 38162618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The review of genetic screening services and common BRCA1/2 variants among South African breast cancer patients.
    Makhetha M; Walters S; Aldous C
    J Genet Couns; 2024 Jun; 33(3):481-492. PubMed ID: 37528630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA Testing for Patients Treated in Italy: A National Survey of Breast Centers Associated with Senonetwork.
    Tinterri C; Gentile D; Caruso F; Cortesi L; De Laurentiis M; Fortunato L; Santini D; Turchetti D; Ferrari A; Zambelli A; Senonetwork Italia Breast Centre Responders
    Curr Oncol; 2024 Jun; 31(7):3815-3825. PubMed ID: 39057154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the development of a decision support intervention for mothers undergoing BRCA1/2 cancer genetic testing regarding communicating test results to their children.
    Peshkin BN; Demarco TA; Tercyak KP
    Fam Cancer; 2010 Mar; 9(1):89-97. PubMed ID: 19609726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.